Background and Objectives: Hormonal receptors are important prognostic fact
ors for breast cancer. The reported figures in the literature are mostly on
Caucasians. This study analyzes the receptor profile of 1,052 Chinese pati
ents.
Methods: The age of the patients ranged from 20-93 years; 48% were premenop
ausal and 52% postmenopausal. Estrogen receptor (ER) and progesterone recep
tor (PgR) were measured quantitatively by enzyme immunoassay (EIA) using th
e rat monoclonal antibody (ABBOTT ER-EIA). Specimens with values >15 fmol/m
g were considered positive according to manufacturer's recommendation.
Results: ER was positive in 53% and 61.6% of the pre- and postmenopausal wo
men respectively (P < 0.0075); PgR was positive in 51.5% and 46.2% respecti
vely (P > 0.05). The mean values of ER were higher for postmenopausal women
(P < 0.0001) but the values for PgR were similar between the two groups (P
> 0.05). When the values were analyzed with respect to age, there was an i
ncreasing trend for ER. No such trend was noted for PgR. Subgroup analysis
showed that there were more ER+PgR+ tumors among postmenopausal than among
premenopausal women. Tumors with dubious receptor status (ER+PgR- or ER-PgR
+) were more prevalent at perimenopausal age.
Conclusions: Chinese patients have lower receptor values and positivity rat
es than those reported for Caucasians. Receptor-positive tumors tend to occ
ur in postmenopausal women. J. Surg. Oncol. 2000:75:172-175. (C) 2000 Wiley
-Liss, Inc. (C) 2000 Wiley-Liss, Inc.